Dan Roseman
About Dan Roseman
Dan Roseman is the Associate Director of Analytical CMC Strategy at Bristol-Myers Squibb and a Scientific Consultant at Discovery & Analytical Development Solutions. He has extensive experience in biopharmaceuticals, having worked at Alexion Pharmaceuticals and Shire, and holds a Ph.D. in Molecular Cell Biology from Washington University in St. Louis.
Current Position at Bristol-Myers Squibb
Dan Roseman holds the position of Associate Director, Analytical CMC Strategy at Bristol-Myers Squibb in Devens, MA. In this role, he is responsible for leading strategies related to Analytical Chemistry, Manufacturing, and Control (CMC) to support the development and commercialization of biopharmaceutical products. His work focuses on ensuring that biopharmaceuticals meet regulatory standards and are analytically sound to move efficiently from development to market.
Role at Discovery & Analytical Development Solutions
Dan Roseman also serves as a Scientific Consultant for Discovery & Analytical Development Solutions in the Greater Boston Area. His responsibilities include offering expert guidance on discovery and development processes within the realm of analytical development. His consultancy role allows him to leverage his extensive knowledge and experience to support innovative approaches in the biopharmaceutical industry.
Background in Biopharmaceutical Research
Dan Roseman has an extensive background in biopharmaceutical research. He served as a Principal Scientist, mRNA Discovery at Alexion Pharmaceuticals, Inc. from 2014 to 2017 in Cambridge, MA, where he focused on mRNA technologies. Prior to that, he worked at Shire, where he held positions as a Senior Scientist and Scientist in Analytical Development from 2002 to 2014. His work at Shire encompassed 12 years of dedicated service in Cambridge, MA, contributing to the company's biopharmaceutical advancements.
Educational Background and Expertise
Dan Roseman has a robust educational background in biochemistry and molecular cell biology. He earned his Ph.D. in Molecular Cell Biology from Washington University in St. Louis, where he studied from 1996 to 2002. Before that, he achieved a Bachelor of Science in Biochemistry from the University of Wisconsin-Madison, where he studied from 1989 to 1993. His academic foundation laid the groundwork for his contributions to the field of biopharmaceutical research and development.
Contributions to Biopharmaceutical Development
Throughout his career, Dan Roseman has developed and implemented patentable and published analytical tools that have significantly contributed to the advancement of biopharmaceutical products to the market. His work involves managing projects and fostering innovation in the drug discovery process. He leads highly productive scientific teams and mentors staff, enhancing their capabilities. His passion for the discovery, characterization, and commercialization of biopharmaceuticals drives his ongoing contributions to the industry.